Dr. Panjwani Center, LNH strengthen research collaboration in infectious diseases, Oncology, AI

KARACHI, (APP - UrduPoint / Pakistan Point News - 22nd May, 2026) Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) and Liaquat National Hospital (LNH) have joined hands to advance research in infectious diseases, oncology, and artificial intelligence.

A high-level delegation from LNH visited the Dr. Panjwani Center at the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, to strengthen the recently established research collaboration between the two institutions, said a spokesperson on Friday.

The visit was followed by the second Memorandum of Understanding signing ceremony, while the first ceremony had earlier been held at Liaquat National Hospital.

The delegation from LNH included Prof. Dr. Salman Faridi, Managing Director; Prof. Dr. Saleha Shahzad, Assistant Managing Director; Prof. Dr. Naila Zahid, Head of Oncology; Prof. Dr. Naveen Faridi, Head of Pathology; Prof. Dr. Sheeraz-ur-Rehman, Head of Surgery; and Prof. Dr. Zia-ul-Islam, Head of Anatomy, along with other senior officials.

The delegation was welcomed by Prof. Dr. Muhammad Raza Shah, Director ICCBS, along with Prof. Dr. Ishtiaq Ahmad Khan and other faculty members of the PCMD.

During the visit, Prof. Dr. Raza Shah delivered a detailed presentation on the history, achievements, and scientific contributions of the Dr. Panjwani Center.

He highlighted the center’s strengths in terms of highly qualified faculty, state-of-the-art equipment, and advanced research infrastructure.

<?php /*?> <?php */?>

He emphasized that collaboration with a healthcare institution of the stature of LNH would significantly contribute toward addressing prevailing health challenges in Pakistan, particularly in Sindh.

Following detailed technical deliberations, three joint working groups were formed to focus on priority research areas, including oncology, infectious diseases, and artificial intelligence.

Speaking on the occasion, Prof. Dr. Salman Faridi stated that the region continued to face an overwhelming burden of infectious diseases, while most treatment protocols were developed in Western countries where the incidence of such diseases is comparatively low.

He stressed upon the need for locally driven research and the development of indigenous treatment protocols based on clinical follow-up data from regional patient populations.

He also highlighted that rise in early-onset cardiac diseases and underscored the importance of utilizing artificial intelligence for the analysis of clinical data, particularly from patients affected by COVID-19 whose medical records are preserved in various hospitals.

The delegation later visited various research centers and laboratories at the Dr. Panjwani Center, interacted with researchers and students, and highly appreciated the institution’s scientific excellence, research environment, and academic contributions.